Chandra Vargeese - 23 Jan 2025 Form 4 Insider Report for Wave Life Sciences Ltd. (WVE)

Role: Chief Technology Officer, Head of Platform Discovery Sciences
Signature: /s/ Chandra Vargeese
Issuer symbol: WVE
Transactions as of: 23 Jan 2025
Net transactions value: +$114,080
Form type: 4
Filing time: 24 Jan 2025, 17:30:03 UTC
Previous filing: 24 Jul 2024
Next filing: 06 Feb 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	WVE	Ordinary Shares	Options Exercise	$114,080	+46,000	+24%	$2.48	233,933	23 Jan 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	WVE	Share Option (right to buy)	Options Exercise	$0	-46,000	-74%	$0.000000	16,422	23 Jan 2025	Ordinary Shares	46,000	$2.48	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 2,872 ordinary shares acquired on January 14, 2025, under the issuer's 2019 Employee Share Purchase Plan.
F2	The share options that were exercised via cash purchase in this reportable transaction were fully vested.

Remarks:

Chief Technology Officer, Head of Platform Discovery Sciences